Drug intelligence / Profile preview

broadline

Development stage
Unknown
Lead developer
Boehringer Ingelheim
Modality
Small Molecules
Administration
Topical
01

Overview

Broadline is a veterinary fixed-dose combination topical formulation containing fipronil, (S)-methoprene, eprinomectin, and praziquantel, used primarily for cats. It is indicated for the treatment and control of mixed infestations of ectoparasites—fleas, ticks, mites—and endoparasites, specifically gastrointestinal nematodes (hookworms, roundworms, lungworms, vesical worms) and cestodes (tapeworms) in cats. - **Fipronil** is a phenylpyrazole insecticide and acaricide acting as an adulticide by blocking ligand-gated chloride channels, particularly those gated by GABA and glutamate, leading to paralysis and death of parasites[7]. - **(S)-methoprene** is an insect growth regulator (IGR) with ovicidal and larvicidal activity, disrupting development by mimicking juvenile hormone and preventing maturation[7]. - **Eprinomectin** is an avermectin endectocide acting systemically against nematodes through high-affinity agonism of glutamate-gated chloride channels, leading to parasite paralysis and death[7]. - **Praziquantel** is a cestocide whose activity is primarily via increasing membrane permeability to calcium in tapeworms, resulting in muscular paralysis and tegumental disruption[7]. The combination provides broad-spectrum protection, including heartworm disease prevention and control of gastrointestinal parasites. It is administered topically as a spot-on solution and approved for use in cats. The product demonstrates high efficacy (>97–100%) against a wide range of feline parasites and is well tolerated[1][7].

Brand names
Broadline
Other names
fipronil + (S)-methoprene + eprinomectin + praziquantel
02

Targets

GluCl (Glutamate-gated chloride channel)MET (Mesenchymal-epithelial transition factor receptor)RDL (Insect GABA-gated chloride channel)

Beyond the preview

Go deeper on broadline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on broadline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call